Aims/hypothesis Sex differences in macrovascular disease, especially in stroke, are observed across studies of epidemiology. We studied a large sample of patients with type 2 diabetes to better understand the relationship between glycaemic control and stroke risk. during follow-up and stroke risk was observed among women (p for trend=0.066). When stratified by race, whether with or without glucose-lowering agents, this graded association of HbA 1c with stroke was still present among women. When stratified by age, the adjusted HRs were significantly higher in women older than 55 years compared with younger women.
Introduction
Stroke is a leading cause of disability, cognitive impairment and death in the USA and accounts for 1.7% of national health expenditures [1] . In the USA, nearly 32,000 more women than men died of stroke in 2000, and this number is predicted to be 68,000 in 2050 [2] . Sex differences in stroke are observed across epidemiological studies, pathophysiology, treatments and outcomes. These sex differences have profound implications for the effective prevention and treatment of stroke. An increased knowledge of stroke risk factors in the population may lead to an improved prevention of stroke.
Epidemiological studies have reported that type 2 diabetes is an independent risk factor for stroke [3] [4] [5] [6] [7] , but how much its effect varies by sex is uncertain. Some studies have shown that type 2 diabetes may have a stronger effect on stroke risk in women [3, 4, [8] [9] [10] , but one study showed a greater effect in men [11] . Because randomised clinical trials (RCTs) and meta-analyses have failed to show the benefit of intensive glucose control on rates of stroke [12] , and with the underrepresentation of females in RCTs [13] , more observational data are needed to assess whether there is a sex-specific association between HbA 1c and the risk of stroke. The aim of the present study was to examine whether the associations between HbA 1c at baseline and during follow-up and the risk of incident stroke are different between men and women with type 2 diabetes in the Louisiana State University HospitalBased Longitudinal Study (LSUHLS).
Methods
Study population LSU Health Care Services Division (LSU HCSD) operates seven public hospitals and affiliated clinics in Louisiana, which provide quality medical care regardless of the patient's income or insurance coverage [14] [15] [16] [17] [18] [19] [20] [21] [22] . Since 1997, administrative, anthropometric, laboratory, clinical diagnosis and medication data have been available in electronic form. The LSUHLS was established in 2010 by using these data [14] . Using ICD-9 (www.icd9data.com/2007/Volume1/ 240-279/250-259/250/default.htm ) (code 250), we established a cohort of diabetic patients who used LSU HCSD hospitals from 1 January 1999 to 31 December 2009. All diabetic patients in the LSU HCSD hospitals were diagnosed using the American Diabetes Association (ADA) criteria: a fasting plasma glucose ≥7.0 mmol/l or 2 h glucose ≥11.1 mmol/l after a 75 g 2 h oral OGTT, or a patient with classic symptoms plus a random plasma glucose level of ≥11.1 mmol/l [23] . In the present study, we only included patients who had newly diagnosed diabetes. Before the diagnosis of diabetes, these patients had used the LSU HSCD system for a mean of 5.0 years (range 2-11 years). We have carried out a validated study for the diagnosis of diabetes in LSU HCSD hospitals [14] , and 20,919 patients from a sample of 21,566 hospital discharge diagnoses based on ICD-9 codes also had physician-confirmed diabetes using the ADA diabetes criteria (the agreement being 97%) [23] .
After excluding individuals with a history of stroke or CHD at baseline and patients with incomplete data on any of the required variables for analysis, the sample included 30,154 patients with type 2 diabetes (10,876 male and 19,278 female). Both the Pennington Biomedical Research Center and LSU Health Sciences Center Institutional Review Boards, LSU System, approved this study and analysis plan. Informed consent was not obtained from the participants involved in our study because we used pseudo-anonymised data compiled from electronic medical records.
Baseline and follow-up measurements The patients' characteristics, including demographic factors (age of diagnosis of diabetes, sex, race/ethnicity, family income, smoking status and types of health insurance), risk factors (body weight, height, BMI, blood pressure, HbA 1c , total cholesterol, HDLcholesterol, LDL-cholesterol, triacylglycerols, estimated GFR [eGFR]) and information on medication (cholesterol-lowering, antihypertensive and glucose-lowering drugs) within a half year after the diagnosis of diabetes (baseline) and during follow-up after the diabetes diagnosis (follow-up) were extracted from the electronic medical records. The calculation of updated mean values of HbA 1c , LDL-cholesterol, BMI, blood pressure and eGFR were performed as previously described [24, 25] . The average number of HbA 1c measurements during the follow-up period was 7.7.
Prospective follow-up We obtained follow-up information on the clinical diagnosis (date of diagnosis, diagnosis code, priority assigned to diagnosis and ICD-9 code) from the LSUHLS inpatient and outpatient database by using the unique number assigned to every patient who visits the LSU HCSD hospitals. The ICD-9 codes were used to identify stroke (ICD-9 codes 430-436) from the LSU HCSD database for a routine clinical care visit. The stroke events occurring before or at the diagnosis of diabetes were identified from the LSU HCSD database retrospectively and were excluded from the analyses. Each cohort member was followed to 31 May 2012 for stroke diagnosis, the date of the last visit if the individual had stopped the use of LSU HCSD hospitals, or death (other than inpatient death from stroke), whichever occurred first [15, 21] . (2) as a continuous variable. The significance of the trend over different categories of HbA 1c was tested in models with the median of each category as a continuous variable. All analyses were adjusted for age and race, and further for smoking, income, type of insurance, BMI, systolic blood pressure, LDLcholesterol, eGFR, use of antihypertensive drugs, use of diabetes medications and use of cholesterol-lowering agents (multivariable model). We adjusted for updated means of BMI, LDL-cholesterol, systolic blood pressure and eGFR instead of these variables at baseline when we analysed the association between the updated means of HbA 1c and stroke risk. Because there was a significant interaction of sex and HbA 1c with stroke risk, men and women were analysed separately. To avoid the potential bias due to the presence of occult diseases at baseline, additional analyses were carried out excluding the participants who were diagnosed with stroke during the first 2 years of follow-up. Statistical significance was considered to be p<0.05. All statistical analyses were performed with PASW for Windows, version 20.0 (IBM SPSS, Chicago, IL, USA).
Statistical analyses

Results
The general characteristics of the study population are presented by sex in Table 1 . During a mean follow-up period of 6.7 years, 2,949 participants (1,093 male and 1,856 female) developed incident stroke (2,848 ischaemic and 115 haemorrhagic). The overall incidence of stroke was higher among men (16.0/1,000 person-years) than women (13.9/ 1,000 person-years). There was a significantly positive association of baseline HbA 1c with stroke risk among females but not males (Table 2) . After further adjustment for other confounding factors (smoking, income, type of insurance, BMI, HbA 1c , LDL-cholesterol, eGFR, use of antihypertensive drugs, use of diabetes medications and use of cholesterollowering agents), this positive association remained significant among females (p for trend <0.001). Each 1% increase in baseline HbA 1c was associated with a 5% (95% CI 1.02, 1.07) increased risk of stroke in females and a 1% (95% CI 0.99, 1.04) increased risk of stroke in males. The risk of stroke associated with HbA 1c was higher in female than in male patient with diabetes (χ 2 =7.85, df=1, p for interaction= 0.005).
The interactions between age and HbA 1c , and between the use of glucose-lowering agents and HbA 1c , and stroke risk were significant (p<0.005 and p<0.001, respectively). This graded positive association of HbA 1c with stroke risk was confirmed among patients with diabetes whether or not they Tables 2, 3 and 4) .
We also compared the absolute sex risk of incident stroke by different HbA 1c levels (Table 5 ). The absolute sex differential for incident stroke appeared only among diabetic patients with an HbA 1c <7.0% (53 mmol/mol) at baseline and <8.0% (64 mmol/mol) during follow-up, and decreased or disappeared among diabetic patients with an HbA 1c >7.0% at baseline and >8.0% during follow-up. Adjusted for age, race, type of insurance, income, smoking, BMI, LDL-cholesterol, systolic blood pressure, eGFR at baseline (in the baseline analyses) and during follow-up (in the follow-up analyses), and use of antihypertensive drugs, glucose-lowering agents and cholesterol-lowering agents
After excluding individuals who were diagnosed with stroke during the first 2 years of follow-up (n =866), the multivariable-adjusted HRs of stroke associated with different levels of HbA 1c did not change (data not shown).
When we performed another analysis by different types of stroke, the result of ischaemic stroke was similar to that for total stroke. For haemorrhagic stroke, a significantly increased risk of stroke (1.72 [CI 1.03, 2.87]) was observed among diabetic patients with HbA 1c <6.0% (42 mmol/mol) during follow-up (data not shown).
Discussion
Our study found a graded positive association between HbA 1c and risk of stroke among female patients with type 2 diabetes, and this graded positive association was more significant in women ≥55 years than in women <55 years of age. In addition, we found that this graded association was present in different race groups and among patients with diabetes who were using glucoselowering agents and those who were not. Epidemiological studies have previously identified differences in stroke occurrence between women and men. Worldwide, stroke is more common among men, but women are more severely ill [26] . These sex differences have profound implications for the effective prevention and treatment of stroke. An increased knowledge of stroke risk factors in the population may lead to an improved prevention of stroke. Epidemiological studies have reported that type 2 diabetes is an independent risk factor for stroke [2] [3] [4] . Some studies have shown that diabetes may have a stronger effect on stroke risk in women than in men [3, 4, [8] [9] [10] . However, a sub-data analysis of the Diabetes Epidemiology: Collaborative analysis Adjusted age, race, type of insurance, income, smoking, BMI, LDL-cholesterol, systolic blood pressure, eGFR at baseline (in the baseline analyses) and during follow-up (in the follow-up analyses), and use of antihypertensive drugs, glucose-lowering agents and cholesterol-lowering agents, other than the variable for stratification of Diagnostic criteria in Europe (DECODE) study showed that diabetes increased stroke risk more in men than in women [11] . There is thus considerable uncertainty, and the magnitude of the risk has not been described in sufficient detail from observational studies. On the other hand, RCTs and even meta-analyses of RCTs have failed to show the benefit of intensive glucose control on rates of stroke [12] , and the under-representation of females in RCTs [13] has limited the power of RCTs to interpret why these sex differences exist.
In the present study, with a mean follow-up of 6.7 years, 2,949 incident cases (1,093 male and 1,856 female) of stroke were identified among 30,154 patients (10,876 male and 19,278 female) with type 2 diabetes. The overall incidence of stroke among men was higher than among women. We found a graded positive association by various HbA 1c intervals of clinical relevance or by using HbA 1c as a continuous variable at baseline and during follow-up with stroke risk among females but not males. The effect of the interaction between race and HbA 1c on stroke risk was not significant. In a previous paper, we described a graded positive association between HbA 1c and CHD in both male and female members of this cohort [22] . In addition, we found that this graded positive association was present in African-American and white female patients and in patients receiving and not receiving treatment with a glucose-lowering agent. There is some inconsistency between the findings for baseline and follow-up HbA 1c , which may suggest that relying on baseline HbA 1c levels alone may lead to biased results.
Several mechanisms could explain why diabetes has a greater adverse effect in women than in men. In the general population, the higher number of strokes occurring among women than men is at least partly attributed to the longer life expectancy of women [27] . Some studies have suggested that the sex difference in cardiovascular risk might come mainly from differences in the levels of cardiovascular risk factors; for example, women with diabetes have significantly higher blood pressure and lipid levels than men with diabetes [28] . Others have suggested that the greater risk associated with diabetes seen in women may reflect a treatment bias that favours men. Several recent studies have found that men with diabetes or cardiovascular disease are more likely than women to receive aspirin, statins or antihypertensive drugs [29] . In our study, after adjusting for systolic blood pressure, LDLcholesterol and medication treatment, this graded association remained significant among females with type 2 diabetes.
When stratified by age, the adjusted HRs were more significantly increased in women ≥55 years than in women <55 years. This might suggest that poor blood glucose control is more harmful in elderly women than in younger ones. The possible explanation may point to a role for oestrogen. After the onset of menopause, when oestrogen levels decline, the incidence of cerebrovascular disease in women increases. Preclinical studies have indicated that oestrogen is neuroprotective and reduces the infarct volume of strokes [30] , but clinical trials have failed to show this benefit [31] [32] [33] . There is a need for more research to clarify this association. In a geriatric population with considerable comorbidities, the competing risk of death is especially high. We described a graded positive association between HbA 1c and CHD in both male and female members in a previous paper [22] . There is a possibility that men with higher HbA 1c values die of CHD rather than having a stroke.
There are several strengths of and limitations to our study. The LSUHLS diabetic cohort is a hospital-based cohort with a large sample size of white and African-American patients with type 2 diabetes. The follow-up time is long, and has allowed for the accumulation of 2,949 incident cases of stroke during follow-up. The confounding influence of healthcare access and socioeconomic status may be minimised in our study samples between white and African-American patients. Since a large proportion of our population are from minority groups and are uninsured individuals with low socioeconomic status, the generalisability of our findings to a middle or high socioeconomic status population may be limited. However, LSU HCSD hospitals are public hospitals and cover over 1.6 million patients, most of whom are low-income persons living in Louisiana. Thus, the results of the current study will have wide applicability for the nearly 50 million Americans who met the poverty criteria in 2012. Second, the stroke diagnoses in our study were based on LSU HCSD hospital discharge registers and have not been confirmed by specialists. However, most American and European cohort studies, such as the Kaiser Permanente Medical Care Program [34, 35] , the Atherosclerosis Risk in Communities Study [36] , the Framingham Study [37] and the National FINRISK Survey [38] , have used the same method to diagnose stroke. The agreement with the diagnosis of stroke by using hospital discharge registers in these cohort studies is 75-90% [35, 39] . Third, only fatal inpatient strokes were included in the outcome. We do not have access to the causes of outpatient death. Fourth, we cannot completely exclude the effects of residual confounding due to measurement errors in the assessment of confounding factors or some unmeasured factors.
Our study demonstrates a graded association between HbA 1c and the risk of stroke among females with type 2 diabetes even though the overall incidence of stroke was higher among men than women. This graded positive association was more significant in women ≥55 years than in women <55 years. This is important to keep in mind when studying blood sugar level and other CVD risk factors in the diabetic population and when planning a strategy to prevent CVD, especially for women with type 2 diabetes.
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